| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |